1.
Curr Oncol
; 29(10): 6749-6753, 2022 09 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36290807
RESUMO
STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic strategy selecting of NSCLC patients harboring STRN-ALK fusion.